Biondo Focus Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Biondo Focus Fund Investor Class BFONX
- NAV / 1-Day Return 21.14 / +0.14 %
- Total Assets 46.3M
-
Adj. Expense Ratio
1.500%
- Expense Ratio 1.500%
- Distribution Fee Level High
- Share Class Type No Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 8%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:55 AM GMT+0
Morningstar’s Analysis BFONX
Will BFONX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 81.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
NVIDIA Corp | 15.59 | 7M | Technology |
Mastercard Inc Class A | 12.72 | 6M | Financial Services |
Intuitive Surgical Inc | 10.58 | 5M | Healthcare |
Apple Inc | 8.57 | 4M | Technology |
Krystal Biotech Inc | 6.81 | 3M | Healthcare |
Amazon.com Inc | 6.03 | 3M | Consumer Cyclical |
ASML Holding NV ADR | 5.96 | 3M | Technology |
Alphabet Inc Class A | 5.93 | 3M | Communication Services |
First American Treasury Obligs X | 5.75 | 3M | Cash and Equivalents |
IDEXX Laboratories Inc | 4.65 | 2M | Healthcare |